Sulfonamides having antiangiogenic and anticancer activity
申请人:——
公开号:US20040157836A1
公开(公告)日:2004-08-12
Compounds having methionine aminopeptidase-2 inhibitory (MetAP2) are described. Also described are pharmaceutical compositions comprising the compounds, methods of treatment using the compounds, methods of inhibiting angiogenesis, and methods of treating cancer.
Exploiting Carbonyl Groups to Control Intermolecular Rhodium-Catalyzed Alkene and Alkyne Hydroacylation
作者:Thomas J. Coxon、Maitane Fernández、James Barwick-Silk、Alasdair I. McKay、Louisa E. Britton、Andrew S. Weller、Michael C. Willis
DOI:10.1021/jacs.7b05713
日期:2017.7.26
Rh-catalyzed intermolecular alkene and alkynehydroacylation reactions. By using cationic rhodium catalysts incorporating bisphosphine ligands, efficient and selective reactions are achieved for β-amido, β-ester, and β-keto aldehyde substrates, providing a range of synthetically useful 1,3-dicarbonyl products in excellent yields. A correspondingly broad selection of alkenes and alkynes can be employed